Risk factors for mortality in healthcare-associated infections caused by Klebsiella pneumoniae

被引:0
作者
Arikan, Burcu Acikalin [1 ]
Korkmaz, Ozge Eren [2 ]
机构
[1] Buca Seyfi Demirsoy Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Izmir, Turkiye
[2] Dokuz Eylul Univ, Dept Epidemiol, Izmir, Turkiye
来源
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE | 2024年 / 15卷 / 09期
关键词
Carbapenem Resistance; Klebsiella Pneumoniae; Hospital Infections; Mortality; Risk Factor;
D O I
10.4328/ACAM.22271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality in hospitals. This study aimed to evaluate the antibiotic resistance profiles and mortality risk factors associated with Klebsiella pneumoniae in healthcare-associated infections. Material and Methods: This cross-sectional, retrospective study was conducted between January 1, 2018, and January 1, 2024. Adult individuals who had K. pneumoniae isolated from clinical samples taken 48 hours after hospitalization and who met healthcare-associated infection criteria were included in the study. The risk factors associated with mortality were evaluated. Results: A total of 84 cases of HAIs caused by K. pneumoniae were included in the study, 47 (56%) of whom were male. Among these, 73.8% exhibited carbapenem-resistant Klebsiella pneumoniae (CRC-Kp). Univariate logistic regression identified chronic obstructive pulmonary disease (COPD), absence of fever response on the fifth day, and CRC-Kp growth as significant mortality predictors. Multivariate analysis revealed patients not on hemodialysis (HD) and absence of fever response on the fifth day as significantly associated with mortality, with 23.774 and 121.620 times higher risk, respectively. Discussion: These findings underscore the threat posed by K. pneumoniae infections due to antibiotic resistance and mortality, highlighting the urgent need for effective infection control measures and targeted treatment strategies.
引用
收藏
页码:635 / 639
页数:5
相关论文
共 18 条
[1]  
Atik TK, 2020, ANKEM Dergisi, V34, P33
[2]   Updated Functional Classification of β-Lactamases [J].
Bush, Karen ;
Jacoby, George A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) :969-976
[3]   Evaluation of risk factors for mortality in intensive care units: A prospective study from a referral hospital in Turkey [J].
Colpan, A ;
Akinci, E ;
Erbay, A ;
Balaban, N ;
Bodur, H .
AMERICAN JOURNAL OF INFECTION CONTROL, 2005, 33 (01) :42-47
[4]  
Duman Y, 2018, MedScience, V7, P536
[5]   Klebsiella pneumoniae: an increasing threat to public health [J].
Effah, Clement Yaw ;
Sun, Tongwen ;
Liu, Shaohua ;
Wu, Yongjun .
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2020, 19 (01)
[6]   Risk Factors of Mortality in Patients with Bloodstream Infections Due to Carbapenem Resistant Klebsiella pneumoniae [J].
Eren, Esma ;
Ulu-Kilic, Aysegul ;
Ture, Zeynep ;
Cevahir, Fatma ;
Kilic, Huseyin ;
Alp-Mese, Emine .
KLIMIK JOURNAL, 2020, 34 (01) :56-60
[7]   Polymicrobial Interactions in the Urinary Tract: Is the Enemy of My Enemy My Friend? [J].
Gaston, Jordan R. ;
Johnson, Alexandra O. ;
Bair, Kirsten L. ;
White, Ashley N. ;
Armbruster, Chelsie E. .
INFECTION AND IMMUNITY, 2021, 89 (04)
[8]   In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015-2017 [J].
Karlowsky, James A. ;
Lob, Sibylle H. ;
Kazmierczak, Krystyna M. ;
Young, Katherine ;
Motyl, Mary R. ;
Sahm, Daniel F. .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 :223-228
[9]   Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis [J].
Li, Dan ;
Huang, Xiangning ;
Rao, Huayun ;
Yu, Hua ;
Long, Shanshan ;
Li, Yulian ;
Zhang, Jie .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
[10]  
Mermutluoglu C, 2023, Van Tip Dergisi, V30, P374